Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of ...

More than 90% of dermatology clinicians surveyed by Leo Pharma say their patients with moderate to severe chronic hand eczema ...

Dermatology providers reported strong impacts on the work and home life of patients with moderate to severe chronic hand eczema, a manifestation of atopic dermatitis.

Delgocitinib cream is efficacious and well-tolerated for the treatment of adults with chronic hand eczema for up to 52 weeks.

Chronic hand eczema (CHE) is a condition separate from eczema, also known as atopic dermatitis, and has a prevalence rate of approximately 4.7% Ninety-five percent (95%) of U.S. dermatology ...

DELTA FORCE is the first head-to-head phase 3 trial comparing a systemic and investigational delgocitinib topical treatment for Chronic Hand Eczema (CHE). 1 The publication summarizes the results ...

DELTA FORCE is the first head-to-head phase 3 trial comparing a systemic and investigational delgocitinib topical treatment for Chronic Hand Eczema (CHE).1 ...